scholarly article | Q13442814 |
P2093 | author name string | D T Miller | |
J Haller | |||
N Blair | |||
E S Gragoudas | |||
J M Seddon | |||
M D Farber | |||
R D Sperduto | |||
R Hiller | |||
T C Burton | |||
U A Ajani | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 1413-1420 | |
P577 | publication date | 1994-11-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. | |
P478 | volume | 272 |
Q34163684 | "Oxidative protector" enzymes in the macular retinal pigment epithelium of aging eyes and eyes with age-related macular degeneration |
Q37003856 | (R)-alpha-lipoic acid protects retinal pigment epithelial cells from oxidative damage |
Q90314811 | 13C-lutein is differentially distributed in tissues of an adult female rhesus macaque following a single oral administration: a pilot study |
Q40405293 | A discordant sib-pair linkage analysis of age-related macular degeneration |
Q33906017 | A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions |
Q54151812 | A hemodynamic model of the pathogenesis of age-related macular degeneration. |
Q46296910 | A lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs |
Q48445779 | A preliminary comparative treatment planning study for radiotherapy of age-related maculopathy. |
Q38802196 | A protective effect of anthocyanins and xanthophylls on UVB-induced damage in retinal pigment epithelial cells |
Q24544001 | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 |
Q92599989 | A review of the putative causal mechanisms associated with lower macular pigment in diabetes mellitus |
Q36069565 | AMD and micronutrient antioxidants. |
Q38916620 | Absorption of Carotenoids and Mechanisms Involved in Their Health-Related Properties. |
Q36223020 | Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study |
Q35845015 | Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis |
Q59446738 | Age-related macular degeneration |
Q74821739 | Age-related macular degeneration |
Q82698020 | Age-related macular degeneration |
Q36815473 | Age-related macular degeneration and recent developments: new hope for old eyes? |
Q31048292 | Age-related macular degeneration: epidemiology and optimal treatment |
Q39714871 | Age-related macular disease |
Q39398083 | An approach to the phytochemical profiling of rocket [Eruca sativa (Mill.) Thell]. |
Q59524799 | An epidemiological investigation of age-related macular degeneration in aged population in China: the Hainan study |
Q51502474 | An evaluation of a novel instrument for measuring macular pigment optical density: the MPS 9000. |
Q77898023 | Analysis of zeaxanthin distribution within individual human retinas |
Q35805387 | Analytical tools for the analysis of β-carotene and its degradation products. |
Q37018870 | Anecortave acetate in the treatment of age-related macular degeneration. |
Q49682945 | Anti-platelet effects of vitamin supplements in age-related macular degeneration: an in vitro study. |
Q41334087 | Antioxidant vitamins and health |
Q44588148 | Are lutein and zeaxanthin conditionally essential nutrients for eye health? |
Q38658699 | Assessment of trans-scleral iontophoresis delivery of lutein to the human retina |
Q36093266 | Association of macular pigment optical density with risk factors for wet age-related macular degeneration in the Indian population |
Q44710321 | Association of neovascular age-related macular degeneration and hyperhomocysteinemia |
Q37588925 | Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular Degeneration. |
Q40047525 | Associations Between Vitamin D Intake and Progression to Incident Advanced Age-Related Macular Degeneration |
Q34366242 | Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration |
Q99406108 | Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration |
Q42359940 | Axial length and subfoveal choroidal thickness in individuals with age-related macular degeneration |
Q33790588 | Bioconversion of dietary provitamin A carotenoids to vitamin A in humans |
Q33358414 | Biological diversity, dietary diversity, and eye health in developing country populations: establishing the evidence-base |
Q28188750 | Body mass index and the incidence of visually significant age-related maculopathy in men |
Q37013392 | C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration |
Q40234151 | Cadmium exposure and age-related macular degeneration |
Q37125125 | Carotenoid intakes, assessed by food-frequency questionnaires (FFQs), are associated with serum carotenoid concentrations in the Jackson Heart Study: validation of the Jackson Heart Study Delta NIRI Adult FFQs. |
Q36524655 | Carotenoids and total phenolic contents in plant foods commonly consumed in Korea |
Q38957329 | Carotenoids: biochemistry, pharmacology and treatment. |
Q35008835 | Carotenoids: separation methods applicable to biological samples |
Q35132383 | Cataract extraction and age-related macular degeneration: associations, diagnosis and management |
Q36628288 | Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration |
Q36139841 | Characterization of the Role of β-Carotene 9,10-Dioxygenase in Macular Pigment Metabolism |
Q33758267 | Cholesterol in the retina: the best is yet to come. |
Q34437319 | Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis |
Q34330189 | Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A |
Q24291318 | Cloning and characterization of a human beta,beta-carotene-15,15'-dioxygenase that is highly expressed in the retinal pigment epithelium |
Q41002492 | Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration |
Q58702202 | Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine |
Q35118257 | Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. |
Q36456926 | Complement dysregulation in AMD: RPE-Bruch's membrane-choroid |
Q46022690 | Complement factor H in AMD: Bridging genetic associations and pathobiology. |
Q92001581 | Construction of a pathway to C50-ε-carotene |
Q54317190 | Contribution of the Nurses' Health Study to the Epidemiology of Cataract, Age-Related Macular Degeneration, and Glaucoma. |
Q26998728 | Critical review: vegetables and fruit in the prevention of chronic diseases |
Q31138791 | Current and future treatment options for nonexudative and exudative age-related macular degeneration. |
Q90095441 | Defining the biosynthesis of ketocarotenoids in Chromochloris zofingiensis |
Q39103783 | Development and characterization of lutein-loaded SNEDDS for enhanced absorption in Caco-2 cells |
Q43476226 | Did the loss of endogenous ascorbate propel the evolution of Anthropoidea and Homo sapiens? |
Q79102077 | Dietary Modification and Moderate Antioxidant Supplementation Differentially Affect Serum Carotenoids, Antioxidant Levels and Markers of Oxidative Stress in Older Humans |
Q37566563 | Dietary and lifestyle risk factors associated with age-related macular degeneration: a hospital based study |
Q24569500 | Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis |
Q36728621 | Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study |
Q47106416 | Dietary guidance for lutein: consideration for intake recommendations is scientifically supported |
Q38529695 | Dietary modification and supplementation for the treatment of age-related macular degeneration |
Q37134473 | Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy |
Q24602331 | Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health |
Q37083770 | Diminishing risk for age-related macular degeneration with nutrition: a current view |
Q28769548 | Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration |
Q42842898 | Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project |
Q34213525 | Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters |
Q33977885 | Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). |
Q38789140 | Dry Age-Related Macular Degeneration Pharmacology |
Q34378033 | Dry age-related macular degeneration: A currently unmet clinical need |
Q37395303 | Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging |
Q84785294 | Effect of 1-year lutein supplementation on macular pigment optical density and visual function |
Q37490460 | Effect of breast feeding on ocular morbidity |
Q46835656 | Effect of low temperature on flavonoids, oxygen radical absorbance capacity values and major components of winter sweet spinach (Spinacia oleracea L.). |
Q61976290 | Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial |
Q40812272 | Effect of lutein and antioxidant supplementation on VEGF expression, MMP-2 activity, and ultrastructural alterations in apolipoprotein E-deficient mouse. |
Q43245703 | Effect of zeaxanthin and antioxidant supplementation on vascular endothelial growth factor (VEGF) expression in apolipoprotein-E deficient mice. |
Q36280084 | Effects of Lutein and Zeaxanthin on LPS-Induced Secretion of IL-8 by Uveal Melanocytes and Relevant Signal Pathways |
Q93055205 | Effects of Macuprev® Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up |
Q44488179 | Effects of a high monounsaturated fat, tomato-rich diet on serum levels of lycopene. |
Q36875178 | Effects of formulation on the bioavailability of lutein and zeaxanthin: a randomized, double-blind, cross-over, comparative, single-dose study in healthy subjects |
Q42536211 | Effects of lutein and cholesterol on alkyl chain bending in lipid bilayers: a pulse electron spin resonance spin labeling study |
Q33845065 | Effects of β-Carotene and Its Cleavage Products in Primary Pneumocyte Type II Cells |
Q36738021 | Elevated Fundus Autofluorescence in Monkeys Deficient in Lutein, Zeaxanthin, and Omega-3 Fatty Acids |
Q53542260 | Employing response surface methodology for the optimization of ultrasound assisted extraction of lutein and β-carotene from spinach. |
Q47128247 | Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration |
Q35560422 | Epidemiology of age-related maculopathy: a review |
Q37575638 | Establishment of a Method for Measuring Antioxidant Capacity in Urine, Based on Oxidation Reduction Potential and Redox Couple I2/KI. |
Q92696059 | Evaluation of macular pigment optical density following femtosecond laser-assisted cataract surgery |
Q35658968 | Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study |
Q28344701 | Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degeneration |
Q33894958 | Evaluation of transgenic tomato plants expressing an additional phytoene synthase in a fruit-specific manner |
Q35552553 | Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies |
Q47116595 | Evolution, Development and Function of Vertebrate Cone Oil Droplets |
Q43946708 | Expression profile of genes coding for carotenoid biosynthetic pathway during ripening and their association with accumulation of lycopene in tomato fruits |
Q50951242 | Familial aggregation of age-related maculopathy. |
Q28066446 | Fish Consumption and Age-Related Macular Degeneration Incidence: A Meta-Analysis and Systematic Review of Prospective Cohort Studies |
Q51954145 | Food habits of Canadians: lutein and lycopene intake in the Canadian population. |
Q24673347 | Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes |
Q37363430 | Functional effect of Saffron supplementation and risk genotypes in early age-related macular degeneration: a preliminary report |
Q27013719 | Genetic and environmental underpinnings to age-related ocular diseases |
Q37302091 | Genetic architecture controlling variation in grain carotenoid composition and concentrations in two maize populations |
Q37537304 | Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). |
Q34027771 | Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach |
Q33831396 | Genetic susceptibility to age related macular degeneration |
Q24622766 | Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) |
Q59085596 | Harvesting sunlight safely |
Q64229464 | Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases |
Q34785911 | Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. |
Q40570133 | Histopathological Insights Into Choroidal Vascular Loss in Clinically Documented Cases of Age-Related Macular Degeneration |
Q28292554 | Human ocular carotenoid-binding proteins |
Q34650775 | Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica |
Q24628314 | Identification of StARD3 as a lutein-binding protein in the macula of the primate retina |
Q42737699 | Identification of alleles of carotenoid pathway genes important for zeaxanthin accumulation in potato tubers. |
Q73572439 | In situ kinetics: an approach to recommended intake of vitamin C |
Q36014754 | In vivo macular pigment measurements: a comparison of resonance Raman spectroscopy and heterochromatic flicker photometry |
Q39533399 | Increased Macular Pigment Optical Density and Visual Acuity following Consumption of a Buttermilk Drink Containing Lutein-Enriched Egg Yolks: A Randomized, Double-Blind, Placebo-Controlled Trial |
Q84597853 | Influence of fruit ripening stage and harvest period on the antioxidant content of sweet pepper cultivars |
Q51775908 | Influence of macular pigment and melanin on incident early AMD in a white population. |
Q46906619 | Intake of zinc and antioxidant micronutrients and early age-related maculopathy lesions |
Q30829406 | Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up |
Q37625442 | Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids |
Q35906378 | Is age-related macular degeneration a problem in Ibadan, Sub-Saharan Africa? |
Q37206264 | Is age-related macular degeneration associated with stroke among elderly americans? |
Q40362063 | Kinetics of 14C distribution after tracer dose of 14C-lutein in an adult woman. |
Q81358633 | Linking the xanthophyll cycle with thermal energy dissipation |
Q64113651 | Liquid antisolvent precipitation: an effective method for ocular targeting of lutein esters |
Q34733171 | Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study |
Q46262751 | Long-term plant stanol and sterol ester-enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density |
Q64039368 | Longitudinal Study of Visual Function in Dry Age-Related Macular Degeneration at 12 Months |
Q47548411 | Lutein Is Differentially Deposited across Brain Regions following Formula or Breast Feeding of Infant Rhesus Macaques |
Q36173190 | Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes |
Q92008650 | Lutein across the Lifespan: From Childhood Cognitive Performance to the Aging Eye and Brain |
Q38901504 | Lutein and Zeaxanthin Isomers in Eye Health and Disease |
Q46853771 | Lutein and antioxidants in the prevention of age-related macular degeneration |
Q36004071 | Lutein and zeaxanthin and their potential roles in disease prevention |
Q42841843 | Lutein and zeaxanthin dietary intake and age related macular degeneration |
Q43833541 | Lutein and zeaxanthin for macular degeneration |
Q34214289 | Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. |
Q37098578 | Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells |
Q26773085 | Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease |
Q30693939 | Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease |
Q37673168 | Lutein and Zeaxanthin-Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection |
Q38702698 | Macular Carotenoid Supplementation Improves Visual Performance, Sleep Quality, and Adverse Physical Symptoms in Those with High Screen Time Exposure |
Q47149024 | Macular Degeneration Epidemiology: Nature-Nurture, Lifestyle Factors, Genetic Risk, and Gene-Environment Interactions - The Weisenfeld Award Lecture |
Q89588604 | Macular Pigment Optical Density in the Korean Population: a Cross Sectional Study |
Q33669515 | Macular pigment and age related macular degeneration |
Q46305501 | Macular pigment and its contribution to visual performance and experience. |
Q37069102 | Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations |
Q33213569 | Macular pigment density in age-related maculopathy. |
Q36239449 | Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center |
Q80078207 | Macular pigment in the human retina: histological evaluation of localization and distribution |
Q39753255 | Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods |
Q35130862 | Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry |
Q31025663 | Macular pigment: quantitative analysis on autofluorescence images |
Q28240096 | Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration |
Q37349992 | Macular zeaxanthins and lutein -- a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease |
Q26776069 | Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies? |
Q33344748 | Measuring macular pigment in vivo |
Q36164956 | Metabolism of lutein and zeaxanthin in rhesus monkeys: identification of (3R,6'R)- and (3R,6'S)-3'-dehydro-lutein as common metabolites and comparison to humans |
Q92409770 | Microalgal Derivatives as Potential Nutraceutical and Food Supplements for Human Health: A Focus on Cancer Prevention and Interception |
Q38061516 | Micronutrients in age-related macular degeneration |
Q50913245 | Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. |
Q35685717 | Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice |
Q37324803 | Molecular genetics of macular dystrophies |
Q37273740 | Molecular pathology of age-related macular degeneration |
Q43006634 | Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration |
Q37003852 | N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration. |
Q38174408 | Nature and nurture- genes and environment- predict onset and progression of macular degeneration. |
Q93387980 | Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD |
Q44110946 | Neovascular age-related macular degeneration and its relationship to antioxidant intake |
Q34634743 | Neuroprotective effects of lutein in the retina |
Q34121906 | New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? |
Q94606534 | New treatments for age-related macular degeneration |
Q39191018 | Nitroxide free radicals protect macular carotenoids against chemical destruction (bleaching) during lipid peroxidation. |
Q38937657 | Non-Dietary Correlates and Determinants of Plasma Lutein and Zeaxanthin Concentrations in the Irish Population |
Q34817164 | Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions |
Q93102835 | Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases |
Q27015832 | Nutrients for the aging eye |
Q34132062 | Nutrition effects on ocular diseases in the aging eye. |
Q74616550 | Nutrition supplements and the eye |
Q38800270 | Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials? |
Q33680428 | Nutritional Interventions against Age-Related Macular Degeneration |
Q37592954 | Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review |
Q35545380 | Nutritional and clinical relevance of lutein in human health |
Q33796324 | Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage |
Q36083941 | Nutritional modulation of age-related macular degeneration. |
Q50242869 | Nutritional quality of eggs from hens fed distillers dried grains with solubles. |
Q34187039 | Nutritional supplementation and age-related macular degeneration |
Q24603642 | Nutritional supplements for age-related macular degeneration |
Q38317289 | Nutritional supplements in age-related macular degeneration |
Q30662463 | Ocular perfusion and age-related macular degeneration. |
Q38930064 | Ophthalmic epidemiology in Europe: the "European Eye Epidemiology" (E3) consortium |
Q34021623 | Ophthalmology update for the primary practitioner. Part II. Therapeutic management of age-related macular degeneration |
Q33722040 | Optimal nutrition: vitamin A and the carotenoids. |
Q92301877 | Oxidative Stress, Diabetic Retinopathy, and Superoxide Dismutase 3 |
Q33774187 | Oxidative damage and age-related macular degeneration |
Q37708674 | Oxidative stress and its downstream signaling in aging eyes. |
Q34000654 | Oxidative stress promotes ocular neovascularization. |
Q36165326 | Pathological consequences of long-term mitochondrial oxidative stress in the mouse retinal pigment epithelium |
Q54868115 | Perceiving polarization with the naked eye: characterization of human polarization sensitivity. |
Q37627442 | Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization |
Q32138422 | Phenotypic heterogeneity in families with age-related macular degeneration |
Q41615449 | Phytochemicals: guardians of our health |
Q35784919 | Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration |
Q38921719 | Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study |
Q41112916 | Polyenes and vision |
Q38698313 | Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications |
Q33396798 | Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables |
Q36853154 | Preventative ophthalmology. Age-related macular degeneration |
Q42778619 | Prevention of age related macular degeneration |
Q34491498 | Prevention of age-related macular degeneration |
Q36964246 | Prevention of retinal light damage by zinc oxide combined with rosemary extract |
Q31952744 | Prevention of visual loss in older adults. |
Q36825090 | Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration |
Q58800107 | Protective Effect of Melatonin against Oxidative Stress-Induced Apoptosis and Enhanced Autophagy in Human Retinal Pigment Epithelium Cells |
Q33308961 | Protective effects of epigallocatechin gallate after UV irradiation in cultured human retinal pigment epithelial cells |
Q61798257 | Quantification of Lutein + Zeaxanthin Presence in Human Placenta and Correlations with Blood Levels and Maternal Dietary Intake |
Q34001750 | R102G polymorphism of the C3 gene associated with exudative age-related macular degeneration in a French population |
Q52657629 | RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells. |
Q24536619 | Race, iris color, and age-related macular degeneration |
Q55246756 | Recent Advances in Studies on the Therapeutic Potential of Dietary Carotenoids in Neurodegenerative Diseases. |
Q37320652 | Red blood cell antioxidant enzymes in age-related macular degeneration |
Q26751293 | Regulation of signaling events involved in the pathophysiology of neovascular AMD |
Q41760612 | Relationships between stress, protein damage, nutrition, and age-related eye diseases |
Q90023787 | Relationships of carotenoid-related gene expression and serum cholesterol and lipoprotein levels to retina and brain lutein deposition in infant rhesus macaques following 6 months of breastfeeding or formula feeding |
Q33231516 | Resonance Raman detection of carotenoid antioxidants in living human tissue |
Q33326556 | Resonance Raman imaging of macular pigment distributions in the human retina |
Q30858951 | Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients |
Q63977092 | Resveratrol Modulates SIRT1 and DNMT Functions and Restores LINE-1 Methylation Levels in ARPE-19 Cells under Oxidative Stress and Inflammation |
Q37196292 | Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium |
Q41119609 | Retinol (vitamin A) supplements in the elderly |
Q77804389 | Reversed-phase high-performance liquid chromatographic identification of lutein and zeaxanthin stereoisomers in bovine retina using a C30 bonded phase |
Q37039797 | Review of genetics in age related macular degeneration. |
Q33431769 | Rhizosphere communities of genetically modified zeaxanthin-accumulating potato plants and their parent cultivar differ less than those of different potato cultivars |
Q34543564 | Risk assessment for the carotenoids lutein and lycopene |
Q24545563 | Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 |
Q39624600 | Risk factors for exudative age-related macular degeneration in a large French case-control study |
Q33900743 | Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors |
Q37298565 | Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD) |
Q28245638 | Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan |
Q47156796 | Scientific Opinion on Dietary Reference Values for vitamin A |
Q47153900 | Scientific Opinion on Dietary Reference Values for vitamin C |
Q47151310 | Scientific Opinion on the re-evaluation of mixed carotenes (E 160a (i)) and beta-carotene (E 160a (ii)) as a food additive |
Q36257030 | Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 |
Q37145586 | Self-nanoemulsifying drug delivery system of lutein: physicochemical properties and effect on bioavailability of warfarin |
Q36921981 | Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density |
Q89471202 | Sequential Paleotetraploidization shaped the carrot genome |
Q93102979 | Serum Lutein is related to Relational Memory Performance |
Q50526262 | Serum beta carotene, alpha tocopherol, and age-related maculopathy: the Blue Mountains Eye Study. |
Q32166645 | Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries |
Q38487855 | Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS). |
Q33572164 | Serum lutein concentrations in healthy term infants fed human milk or infant formula with lutein |
Q34817132 | Simple Raman instrument for in vivo detection of macular pigments |
Q42918532 | Simultaneous HPLC‐DAD‐MS (ESI+) determination of structural and geometrical isomers of carotenoids in mature grapes |
Q37166430 | Single food focus dietary guidance: lessons learned from an economic analysis of egg consumption |
Q55259002 | Six-Year Incidence and Risk Factors of Age-Related Macular Degeneration in Singaporean Indians: The Singapore Indian Eye Study. |
Q36050310 | Skin carotenoid status measured by resonance Raman spectroscopy as a biomarker of fruit and vegetable intake in preschool children |
Q34394380 | Smoking and age-related macular degeneration: review and update |
Q59112099 | Spatial and Temporal Variation of Carotenoids in Four Species of Trentepohlia (Trentepohliales, Chlorophyta) |
Q28259126 | Spirulina is an effective dietary source of zeaxanthin to humans |
Q37151405 | Structure of the lutein-binding domain of human StARD3 at 1.74 Å resolution and model of a complex with lutein |
Q33862795 | Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults |
Q38290354 | Surface plasmon resonance (SPR)-based biosensor technology for the quantitative characterization of protein-carotenoid interactions |
Q93157135 | Systematic review of the appropriateness of eye care delivery in eye care practice |
Q28219450 | TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD |
Q39092535 | The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration |
Q36360812 | The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) |
Q48570003 | The Bowman lecture. Towards an understanding of age-related macular disease. |
Q35716443 | The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study |
Q58722677 | The Effect of Lutein on Eye and Extra-Eye Health |
Q26769895 | The Photobiology of Lutein and Zeaxanthin in the Eye |
Q58611705 | The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis |
Q61889991 | The association between dark adaptation and macular pigment optical density in healthy subjects |
Q42978581 | The carotenoids of some food stuffs in Saudi Arabia. |
Q34635706 | The effect of lutein- and zeaxanthin-rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers |
Q61976272 | The effect of nutritional supplementation on the multifocal electroretinogram in healthy eyes |
Q45683269 | The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy -- a randomised controlled trial |
Q92463735 | The growth and development of cress (Lepidium sativum) affected by blue and red light |
Q46542128 | The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study |
Q35895835 | The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation |
Q34056004 | The potential role of dietary xanthophylls in cataract and age-related macular degeneration |
Q36317120 | The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. |
Q42691402 | The rate of myocardial infarction events among patients with age-related macular degeneration: a population-based study |
Q33682081 | The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. |
Q33278684 | The role of heredity in determining central retinal thickness. |
Q37002600 | The role of lutein in eye-related disease |
Q35028928 | The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration. |
Q34635193 | The role of phytonutrients in skin health |
Q73191249 | The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration |
Q24802193 | The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence |
Q35465063 | The self-reported clinical practice behaviors of Australian optometrists as related to smoking, diet and nutritional supplementation |
Q35981098 | The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation |
Q33733227 | The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders |
Q43006737 | Total parenteral nutrition, vitamin E, and reversible macular dysfunction morphologically mimicking age related macular degeneration |
Q34174002 | Transcriptome changes in age-related macular degeneration. |
Q73939433 | Treatment of age-related macular degeneration |
Q54571267 | Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis. |
Q47435634 | Twin study of age-related macular degeneration |
Q58709984 | Two Likely Auto-Tetraploidization Events Shaped Kiwifruit Genome and Contributed to Establishment of the Actinidiaceae Family |
Q33410528 | Uncultivated Brazilian green leaves are richer sources of carotenoids than are commercially produced leafy vegetables |
Q55398351 | Unhealthy behaviours and risk of visual impairment: The CONSTANCES population-based cohort. |
Q41011950 | Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids |
Q73715929 | Use of a 13C tracer to quantify the plasma appearance of a physiological dose of lutein in humans |
Q37964705 | Use of herbal medicines and nutritional supplements in ocular disorders: an evidence-based review |
Q57224317 | Use of high-precision gas isotope ratio mass spectrometry to determine natural abundance 13C in lutein isolated from C3 and C4 plant sources |
Q33812682 | Vegetarian diet: panacea for modern lifestyle diseases? |
Q24676430 | Violet and blue light blocking intraocular lenses: photoprotection versus photoreception |
Q36866107 | Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics |
Q59446743 | What do we know about the macular pigment in AMD: the past, the present, and the future |
Q77170547 | What's new in ophthalmic surgery |
Q37261208 | Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway |
Q44387561 | Zeaxanthin accumulation in the absence of a functional xanthophyll cycle protects Chlamydomonas reinhardtii from photooxidative stress |
Q36844157 | Zeaxanthin and α-tocopherol reduce the inhibitory effects of photodynamic stress on phagocytosis by ARPE-19 cells |
Q41843418 | Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1α. |
Q46718576 | Zeaxanthin is bioavailable from genetically modified zeaxanthin-rich potatoes |
Q90079447 | Zeaxanthin: Metabolism, Properties, and Antioxidant Protection of Eyes, Heart, Liver, and Skin |
Q26765250 | Zeaxanthin: Review of Toxicological Data and Acceptable Daily Intake |
Q44626255 | Zinc and energy requirements in induction of oxidative stress to retinal pigmented epithelial cells |
Q81778481 | ["Do you have a remedy for macular degeneration?" A field study about the advice given on dietary supplementation in 60 German pharmacies] |
Q80476063 | [Toward prevention of age-related macular degeneration] |
Q33508828 | rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration |
Q42718232 | sA population-based study of macular choroidal neovascularization using optical coherence tomography in Eastern China |
Search more.